Ignite Creation Date:
2025-12-24 @ 7:32 PM
Ignite Modification Date:
2026-01-01 @ 1:17 AM
Study NCT ID:
NCT00110903
Status:
COMPLETED
Last Update Posted:
2013-04-26
First Post:
2005-05-16
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Treatment for Subjects With Active Rheumatoid Arthritis (RA)
Sponsor:
Amgen
Organization:
Study Overview
Official Title:
Open-Label Study to Assess the Safety of Etanercept Liquid Administered Once Weekly in Subjects With Active Rheumatoid Arthritis (RA)
Status:
COMPLETED
Status Verified Date:
2013-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to assess the safety of etanercept liquid administered once weekly to subjects with RA.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?: